Farmas USA

... y luego esta a la que llamamos, la novia cadaver ...THLD.

MNKD El mínimo de 52 semanas en 4,45 aguanta (con la que está cayendo). A ver si va a ser buena entrada
Edito: fuera mínimo. Caida libre

OXGN 1.42
-0.35%

XBI 210.90
-2.25%
ANY 3.30
-0.30%
XLV 72.44
-0.41%
IBB 338.54
-1.82%

THLD. Dentro 3k cromos mas en 3,64. Y se acabo de comprar! Tenia la orden en 3,62 por aquello de comprar al precio de la dilución de Febrero pero ya esta hecho.   

OCAT

Publicación de Corea a punto de salir. En realidad parece que ha salido o se ha filtrado y lo han retirado. Por lo pronto, se ha recopilado lo siguiente, que confirma los buenos resultados del Lancet. A ver si consigue impresionar al mercado.

A study of four patients published in Stem Cell Reports on 30 April[1] suggests that treatment with stem cell-derived retinal cells can arrest, and perhaps even modestly improve, the eyesight of patients with macular degeneration.... were able to read 9 to 19 more letters on an eye chart a year after treatment.

A company that has spent more than 20 years trying to develop treatments based on embryonic stem cells is taking encouragement from tests .

Early trials suggest vision gains for Asian patients with eye disease. ... and perhaps even modestly improve, the eyesight of patients with macular ... In patients with macular degeneration, this layer is gradually lost -- along with .

Early trials suggest vision gains for Asian patients with eye disease. ...Nature | News ... modestly improve, the eyesight of patients with maculardegeneration. ... Korea, three recipients of the therapy were able to read 9 to 19 more letters ... “This bodes well,” says Robert Lanza, chief scientific officer at Ocata

CeLeDoNio

Parece que van subiendo algo, poquita cosa.

OCAT

Es del Nature y aparece en la búsqueda de Google como publicado ayer, pero el enlace da error. Estará al caer...

https://www.google.es/?gfe_rd=cr&ei=ZFBCVZnNIZOt8wf25IC4Cw#q=%22Stem+cell+therapy+shows+hints+of+success+against+vision+loss%22

http://www.nature.com/news/stem-cell-therapy-shows-hints-of-success-against-vision-loss-1.17451

IDRA

Ahora sí que está en su punto para entrar.

Edito: gap cerrado al completo.